Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis (Q68950889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

M H Sjogren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J H Hoofnagle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J G Waggoner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

language of work or name

English

0 references

publication date

1 May 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

582-585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

Virus replication and liver disease in chronic hepatitis B virus infection

28 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Prevalence and Significance of Anti-HBc IgM (Radioimmunoassay) in Acute and Chronic Hepatitis B and in Blood Donors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Detection of anti-HBc IgM following prednisone treatment in patients with chronic active hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070328

7 January 2021

Identifiers

DOI

10.1002/HEP.1840070328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552925%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference